Reaktionsgleichung
[Br:1][C:2]1[C:3]([Cl:11])=[N:4][CH:5]=[C:6]([CH:10]=1)[C:7]([OH:9])=O.[F:12][C:13]([F:25])([C:18]1[CH:24]=[CH:23][C:21]([NH2:22])=[CH:20][CH:19]=1)[C:14]([F:17])([F:16])[F:15]>>[Br:1][C:2]1[C:3]([Cl:11])=[N:4][CH:5]=[C:6]([CH:10]=1)[C:7]([NH:22][C:21]1[CH:20]=[CH:19][C:18]([C:13]([F:12])([F:25])[C:14]([F:15])([F:16])[F:17])=[CH:24][CH:23]=1)=[O:9]Komponenten
3
Versuchsvorschrift
The title compound was prepared in an analogous fashion to that described in Stage 11.2 using 5-bromo-6-chloro-nicotinic acid and 4-pentafluoroethyl-aniline to afford a white crystalline solid. HPLC (Condition 4) tR=6.61 min, UPLC-MS (Condition 3) tR=1.32 min, m/z=429 [M−H]−.
Aufarbeitung
- customto afford a white crystalline solid
Quellen und Nachweise
- ORD-Eintrag
- ord-7960dd31f1db4e9b9ea4d410a00d6e98
- Quelldatensatz
- uspto-grants-2014_09
- Patentnummer
- US08829195B2
Verknüpfte Notizen
Wird geladen…